Keros Therapeutics, Inc.
KROS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$187 | -$153 | -$105 | -$59 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $35 | $29 | $19 | $12 |
| Change in WC | -$11 | -$3 | $14 | -$16 |
| Other Non-Cash | $2 | $2 | $1 | $1 |
| Operating Cash Flow | -$161 | -$125 | -$70 | -$62 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$2 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2 | -$2 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $380 | $176 | $120 | $28 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $12 | $3 | $1 | $0 |
| Financing Cash Flow | $392 | $179 | $120 | $29 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $229 | $52 | $49 | -$35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $332 | $280 | $231 | $266 |
| End Cash | $561 | $332 | $280 | $231 |
| Free Cash Flow | -$163 | -$127 | -$71 | -$63 |